Refine
Has Fulltext
- yes (28)
Is part of the Bibliography
- yes (28)
Document Type
- Journal article (28)
Keywords
- breast cancer (11)
- 3D printing (4)
- gynecology (4)
- ovarian cancer (4)
- education (3)
- teaching (3)
- BRENDA (2)
- ECMO-Therapie (2)
- Metastatic breast cancer (2)
- VEGF (2)
- blood-brain barrier (2)
- lymph nodes (2)
- pelvic examination (2)
- pelvic palpation (2)
- pregnancy (2)
- survival (2)
- visualization (2)
- 3D tissue model (1)
- Blood–brain barrier (1)
- CD39 (1)
- CD73 (1)
- COVID-19 (1)
- COVID-19-ARDS (1)
- COVID-19-Pademie (1)
- CX3CL1 (1)
- CXCL13 (1)
- Covid-19 (1)
- ECMO therapy (1)
- FDM (1)
- Geburtshilfe (1)
- Geburtshilfliche Intensivmedizin (1)
- HER2 conversion (1)
- HER2 targeted therapy (1)
- HER2-low (1)
- Health care service research (1)
- In vitro models (1)
- Infektionswellen (1)
- Large loop excision of the transformation zone (LLETZ) (1)
- Loop electrosurgical excision procedure (LEEP) (1)
- Nectin‐2 (1)
- Patient-centered registry (1)
- Patient’s needs (1)
- Pelvisio® (1)
- SLA (1)
- Schwangerschaft (1)
- T cells (1)
- VE-cadherin (1)
- accessibility (1)
- adenosine (1)
- advanced breast cancer (1)
- anti-hormonal therapy (1)
- ascites (1)
- axillary dissection (1)
- bone metastases (1)
- brain-metastasis (1)
- breast cancer imaging (1)
- breast cancer metastases (1)
- breast cancer subtypes (1)
- cancer chemotherapy (1)
- cancer detection and diagnosis (1)
- cancer dissemination (1)
- cancer microenvironment (1)
- cancer treatment (1)
- cervical dysplasia (1)
- chemotherapy (1)
- claudin 5 (1)
- co-culture (1)
- conventional imaging (1)
- cross-sectional imaging (1)
- delay of therapy (1)
- dysplasia (1)
- endocrine therapy (1)
- evidence‐based medicine (1)
- exosomes (1)
- follow up (1)
- fused deposition modeling (FDM) (1)
- gene expression (1)
- geographic information science (1)
- guideline adherent treatment (1)
- health care service research (1)
- histopathology (1)
- hormona therapy (1)
- hormones (1)
- immune escape (1)
- immunotherapy (1)
- implementation (1)
- ionizing radiation (1)
- ketogenic diet (1)
- ketone bodies (1)
- large loop excision of the transformation zone (LLETZ) (1)
- m-Health (1)
- mammography (1)
- metabolic profile (1)
- metastasis (1)
- microRNA (1)
- neoadjuvant therapies (1)
- number of (1)
- patient safety (1)
- patient serum (1)
- peritoneal metastasis (1)
- polyvinylidene fluoride (PVDF) (1)
- positive nodal status (1)
- post-neoadjuvant therapies (1)
- prediction (1)
- prognosis (1)
- prognostic marker (1)
- psychological distress (1)
- quality of care (1)
- risk (1)
- robotic complications (1)
- robotic hysterectomy (1)
- robotic sacrocolpopexy (1)
- score (1)
- seahorse (1)
- sentinel (1)
- simulation (1)
- skeleton (1)
- stress (1)
- trastuzumab (1)
- trastuzumab deruxtecan (1)
- tumor associated macrophages (1)
- tumor size (1)
- tumour immunology (1)
- ultrasound (1)
- vascular permeability (1)
- virtual (1)
- β-Hydroxybutyrate (1)
Institute
- Frauenklinik und Poliklinik (28)
- Klinik und Poliklinik für Anästhesiologie (ab 2004) (6)
- Theodor-Boveri-Institut für Biowissenschaften (3)
- Institut für Klinische Epidemiologie und Biometrie (2)
- Institut für Virologie und Immunbiologie (2)
- Institut für diagnostische und interventionelle Radiologie (Institut für Röntgendiagnostik) (2)
- Kinderklinik und Poliklinik (2)
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (2)
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (2)
- Institut für Geographie und Geologie (1)
Immune checkpoint blockade therapy is beneficial and even curative for some cancer patients. However, the majority don’t respond to immune therapy. Across different tumor types, pre-existing T cell infiltrates predict response to checkpoint-based immunotherapy. Based on in vitro pharmacological studies, mouse models and analyses of human melanoma patients, we show that the cytokine GDF-15 impairs LFA-1/β2-integrin-mediated adhesion of T cells to activated endothelial cells, which is a pre-requisite of T cell extravasation. In melanoma patients, GDF-15 serum levels strongly correlate with failure of PD-1-based immune checkpoint blockade therapy. Neutralization of GDF-15 improves both T cell trafficking and therapy efficiency in murine tumor models. Thus GDF-15, beside its known role in cancer-related anorexia and cachexia, emerges as a regulator of T cell extravasation into the tumor microenvironment, which provides an even stronger rationale for therapeutic anti-GDF-15 antibody development.